Zimmer Biomet Holdings (ZBH) reported Q4 adjusted earnings Thursday of $2.31 per diluted share, up from $2.20 a year earlier.
One analyst polled by FactSet expected $1.73.
Net sales for the quarter ended Dec. 31 were $2.02 billion, up from $1.94 billion a year earlier.
Analysts surveyed by FactSet expected $2.01 billion.
The company said it expects 2025 adjusted earnings of $8.15 to $8.35 per diluted share, with revenue growing by 1.0% to 3.5%.
Two analysts surveyed by FactSet expect 2025 adjusted EPS of $7.43.
Zimmer Biomet shares were down by more than 2% in recent premarket activity.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。